Pharmacodynamics: How Drugs Interact with Receptors

Efficacy (Intrinsic Activity)

Efficacy, or intrinsic activity, is the capacity of a drug-receptor complex to produce a functional change in the cell. Even if a drug binds tightly to a receptor, it will only produce a physiological effect if it possesses efficacy.

Agonists and Antagonists

Based on their ability to bind and activate receptors, drugs are primarily classified into two categories: agonists and antagonists.

1. Agonists

An agonist is a drug that binds to a receptor and activates it to produce a biological response. Agonists are essentially "mimics."

• Full Agonists: These drugs bind to the receptor and produce the maximum possible biological response that the system can provide. They have high efficacy.
• Partial Agonists: These drugs bind to the receptor but, even at 100% receptor occupancy, they cannot produce the same maximal response as a full agonist. They possess moderate efficacy. In the presence of a full agonist, a partial agonist may actually act as an inhibitor by competing for the same sites.

2. Antagonists

An antagonist is a drug that binds to a receptor but does not activate it. It has affinity, but zero efficacy. Its primary function is to prevent other molecules (like endogenous hormones or agonists) from binding to the receptor.

Antagonists are further categorized by how they interact with the receptor:

• Competitive Antagonists: These compete directly with the agonist for the same binding site. Because the binding is reversible, the effect of a competitive antagonist can be overcome by increasing the concentration of the agonist.
• Non-competitive Antagonists: These bind to a different site on the receptor (an allosteric site) or bind irreversibly to the active site. This changes the receptor's shape or permanently disables it, meaning no amount of agonist can overcome the blockade.

Summary Table: Drug-Receptor Interactions

A Worked Example: The Adrenergic System

To visualize these concepts, consider the $\beta$-adrenergic receptors in the heart, which respond to the natural hormone epinephrine (adrenaline).

1. The Endogenous Ligand: Epinephrine binds to $\beta$-receptors, increasing heart rate and contractility (Full Agonist action).
2. The Agonist: A drug like Isoproterenol mimics epinephrine, binding to the receptor and significantly increasing heart rate to treat certain bradycardia conditions.
3. The Antagonist: A drug like Propranolol (a $\beta$-blocker) binds to these same receptors but does not activate them. By sitting in the receptor "lock," it prevents epinephrine from binding, thereby lowering heart rate and blood pressure.

By manipulating these receptor-ligand interactions, pharmacologists can design drugs that either amplify or dampen specific physiological pathways to treat disease.